✦ LIBER ✦

Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation

✍ Scribed by C. Gemmel; F. Cremer; M. Weis; M. Witzens; G. Moldenhauer; K.-H. Koniczek; U. Imbach; A. Ho; M. Moos; H. Goldschmidt

Publisher: Springer
Year: 2001
Tongue: English
Weight: 67 KB
Volume: 81
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-001-0397-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphoproliferative syndrome in an infan

Lymphoproliferative syndrome in an infant after stem cell transplantation: Successful therapy with T-lymphocytes and anti-CD20 monoclonal antibodies

✍ Stachel, Daniel K. ;Schmid, Irene ;Schuster, Friedhelm ;Stehr, Maximilian ;Baume 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

High-dose melphalan is an effective salv

High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation

✍ Gesine Bug; Johannes Atta; Stefan A. Klein; Bernd Hertenstein; Lothar Bergmann; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 107 KB

Vanishing bile duct syndrome occurring a

Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin’s disease

✍ Ş. Kömürcü; A. Özet; M. Altundag; F. Arpaci; B. Öztürk; B. Celasun; Y. Tezcan 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 43 KB

Tandem high-dose therapy in relapsed and

Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with131I-anti-CD20 antibody and stem cell rescue

✍ Karin Hohloch; Carsten Oliver Sahlmann; Vijai J. Lakhani; Gerald Wulf; Bertram G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 233 KB

Sequential vincristine, adriamycin, dexa

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel